These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28820074)

  • 61. The role of adiponectin in metabolic and vascular disease: a review.
    Cui J; Panse S; Falkner B
    Clin Nephrol; 2011 Jan; 75(1):26-33. PubMed ID: 21176748
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Research progress in regulation of adiponectin receptors expression].
    Cui XB; Han Y; Li L; Wu LL
    Sheng Li Ke Xue Jin Zhan; 2011 Jun; 42(3):169-74. PubMed ID: 21932513
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Adiponectin, an unlocking adipocytokine.
    Sun Y; Xun K; Wang C; Zhao H; Bi H; Chen X; Wang Y
    Cardiovasc Ther; 2009; 27(1):59-75. PubMed ID: 19207481
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Adiponectin, the past two decades.
    Wang ZV; Scherer PE
    J Mol Cell Biol; 2016 Apr; 8(2):93-100. PubMed ID: 26993047
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Regulation of T-cadherin by hormones, glucocorticoid and EGF.
    Bromhead C; Miller JH; McDonald FJ
    Gene; 2006 Jun; 374():58-67. PubMed ID: 16516410
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The multifaceted and controversial immunometabolic actions of adiponectin.
    Esmaili S; Xu A; George J
    Trends Endocrinol Metab; 2014 Sep; 25(9):444-51. PubMed ID: 24997879
    [TBL] [Abstract][Full Text] [Related]  

  • 68. T-cadherin attenuates insulin-dependent signalling, eNOS activation, and angiogenesis in vascular endothelial cells.
    Philippova M; Joshi MB; Pfaff D; Kyriakakis E; Maslova K; Erne P; Resink TJ
    Cardiovasc Res; 2012 Mar; 93(3):498-507. PubMed ID: 22235028
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Emerging importance of chemokine receptor CXCR3 and its ligands in cardiovascular diseases.
    Altara R; Manca M; Brandão RD; Zeidan A; Booz GW; Zouein FA
    Clin Sci (Lond); 2016 Apr; 130(7):463-78. PubMed ID: 26888559
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Adiponectin receptor as a key player in healthy longevity and obesity-related diseases.
    Yamauchi T; Kadowaki T
    Cell Metab; 2013 Feb; 17(2):185-96. PubMed ID: 23352188
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Adiponectin and cardiovascular disease: response to therapeutic interventions.
    Han SH; Quon MJ; Kim JA; Koh KK
    J Am Coll Cardiol; 2007 Feb; 49(5):531-8. PubMed ID: 17276175
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adiponectin receptors: a review of their structure, function and how they work.
    Yamauchi T; Iwabu M; Okada-Iwabu M; Kadowaki T
    Best Pract Res Clin Endocrinol Metab; 2014 Jan; 28(1):15-23. PubMed ID: 24417942
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Adiponectin and cardiovascular disease: mechanisms and new therapeutic approaches.
    Siasos G; Tousoulis D; Kollia C; Oikonomou E; Siasou Z; Stefanadis C; Papavassiliou AG
    Curr Med Chem; 2012; 19(8):1193-209. PubMed ID: 22257055
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Adiponectin receptor binding proteins--recent advances in elucidating adiponectin signalling pathways.
    Buechler C; Wanninger J; Neumeier M
    FEBS Lett; 2010 Oct; 584(20):4280-6. PubMed ID: 20875820
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Role of adiponectin in sphingosine-1-phosphate induced airway hyperresponsiveness and inflammation.
    Nigro E; Matteis M; Roviezzo F; Mattera Iacono V; Scudiero O; Spaziano G; Tartaglione G; Urbanek K; Filosa R; Daniele A; D'Agostino B
    Pharmacol Res; 2016 Jan; 103():114-22. PubMed ID: 26462929
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Research advances in the regulation of cardiovascular metabolic disorders and its related risk factors by C1q/TNF related proteins].
    Zhang SH; DU YH; Yu HC; Li YM; Liu HR
    Sheng Li Xue Bao; 2018 Jun; 70(3):310-318. PubMed ID: 29926073
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Adiponectin Enhances Cold-Induced Browning of Subcutaneous Adipose Tissue via Promoting M2 Macrophage Proliferation.
    Hui X; Gu P; Zhang J; Nie T; Pan Y; Wu D; Feng T; Zhong C; Wang Y; Lam KS; Xu A
    Cell Metab; 2015 Aug; 22(2):279-90. PubMed ID: 26166748
    [TBL] [Abstract][Full Text] [Related]  

  • 78. mRNA abundance of adiponectin and its receptors, leptin and visfatin and of G-protein coupled receptor 41 in five different fat depots from sheep.
    Lemor A; Mielenz M; Altmann M; von Borell E; Sauerwein H
    J Anim Physiol Anim Nutr (Berl); 2010 Oct; 94(5):e96-101. PubMed ID: 20546074
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tiliroside, a glycosidic flavonoid, ameliorates obesity-induced metabolic disorders via activation of adiponectin signaling followed by enhancement of fatty acid oxidation in liver and skeletal muscle in obese-diabetic mice.
    Goto T; Teraminami A; Lee JY; Ohyama K; Funakoshi K; Kim YI; Hirai S; Uemura T; Yu R; Takahashi N; Kawada T
    J Nutr Biochem; 2012 Jul; 23(7):768-76. PubMed ID: 21889885
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Undernutrition during suckling in rats elevates plasma adiponectin and its receptor in skeletal muscle regardless of diet composition: a protective effect?
    Prior LJ; Velkoska E; Watts R; Cameron-Smith D; Morris MJ
    Int J Obes (Lond); 2008 Oct; 32(10):1585-94. PubMed ID: 18725894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.